Raras
Buscar doenças, sintomas, genes...
Diabetes mellitus genéticos raros
ORPHA:183625DOENÇA RARA

Diabetes mellitus causado por mutações em um único gene.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Diabetes mellitus causado por mutações em um único gene.

🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

📏
Crescimento
25 sintomas
🧠
Neurológico
24 sintomas
🫘
Rins
23 sintomas
🫃
Digestivo
22 sintomas
🦴
Ossos e articulações
14 sintomas
😀
Face
8 sintomas

+ 67 sintomas em outras categorias

Características mais comuns

Escoliose toracolombar
Síndrome de Fanconi renal
Ducto deferente atrésico
Contratura das articulações dos membros inferiores
Obesidade
Apneia
201sintomas
Sem dados (201)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 201 características clínicas mais associadas, ordenadas por frequência.

Escoliose toracolombarThoracolumbar scoliosis
Síndrome de Fanconi renalRenal Fanconi syndrome
Ducto deferente atrésicoAtretic vas deferens
Contratura das articulações dos membros inferioresContractures of the joints of the lower limbs
ObesidadeObesity

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa2
Últimos 10 anos200publicações
Pico2025144 papers
Linha do tempo
2024Hoje · 2026🧪 2009Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

22 genes identificados com associação a esta condição.

GCKMitogen-activated protein kinase kinase kinase kinase 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Serine/threonine-protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Acts as a MAPK kinase kinase kinase (MAP4K) and is an upstream activator of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway and to a lesser extent of the p38 MAPKs signaling pathway. Required for the efficient activation of JNKs by TRAF6-dependent stimuli, including pathogen-associated molecular patterns (PAMPs) such as polyinosine-polycytidi

LOCALIZAÇÃO

CytoplasmBasolateral cell membraneGolgi apparatus membrane

VIAS BIOLÓGICAS (5)
GlycolysisRegulation of gene expression in beta cellsRegulation of Glucokinase by Glucokinase Regulatory ProteinDefective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
EXPRESSÃO TECIDUAL(Tecido-específico)
Pituitária
34.5 TPM
Cérebro - Hemisfério cerebelar
7.2 TPM
Cerebelo
7.1 TPM
Hipotálamo
6.5 TPM
Coração - Átrio
3.1 TPM
OUTRAS DOENÇAS (7)
type 2 diabetes mellitusmaturity-onset diabetes of the young type 2permanent neonatal diabetes mellitus 1monogenic diabetes
HGNC:4195UniProt:Q12851
HNF1AHepatocyte nuclear factor 1-alphaDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcriptional activator that regulates the tissue specific expression of multiple genes, especially in pancreatic islet cells and in liver (By similarity). Binds to the inverted palindrome 5'-GTTAATNATTAAC-3' (PubMed:10966642, PubMed:12453420). Activates the transcription of CYP1A2, CYP2E1 and CYP3A11 (By similarity) (Microbial infection) Plays a crucial role for hepatitis B virus gene transcription and DNA replication. Mechanistically, synergistically cooperates with NR5A2 to up-regulate the

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Regulation of gene expression in beta cells
MECANISMO DE DOENÇA

Hepatic adenomas familial

Rare benign liver tumors of presumable epithelial origin that develop in an otherwise normal liver. Hepatic adenomas may be single or multiple. They consist of sheets of well-differentiated hepatocytes that contain fat and glycogen and can produce bile. Bile ducts or portal areas are absent. Kupffer cells, if present, are reduced in number and are non-functional. Conditions associated with adenomas are insulin-dependent diabetes mellitus and glycogen storage diseases (types 1 and 3).

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
8.7 TPM
Intestino delgado
6.3 TPM
Rim - Córtex
5.3 TPM
Cólon transverso
4.3 TPM
Estômago
4.1 TPM
OUTRAS DOENÇAS (11)
maturity-onset diabetes of the young type 3nonpapillary renal cell carcinomahepatic adenomas, familialtype 1 diabetes mellitus 20
HGNC:11621UniProt:P20823
KCNJ11ATP-sensitive inward rectifier potassium channel 11Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Inward rectifier potassium channel that forms the pore of ATP-sensitive potassium channels (KATP), regulating potassium permeability as a function of cytoplasmic ATP and ADP concentrations in many different cells (PubMed:29286281, PubMed:34815345). Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (6)
Ion homeostasisABC-family proteins mediated transportDefective ABCC9 causes CMD10, ATFB12 and Cantu syndromeDefective ABCC8 can cause hypo- and hyper-glycemiasRegulation of insulin secretion
MECANISMO DE DOENÇA

Hyperinsulinemic hypoglycemia, familial, 2

A form of hyperinsulinemic hypoglycemia, a clinically and genetically heterogeneous disorder characterized by inappropriate insulin secretion from the pancreatic beta-cells in the presence of low blood glucose levels. HHF2 is a common cause of persistent hypoglycemia in infancy. Unless early and aggressive intervention is undertaken, brain damage from recurrent episodes of hypoglycemia may occur. HHF2 inheritance can be autosomal dominant or autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
87.1 TPM
Cerebelo
37.4 TPM
Cérebro - Hemisfério cerebelar
36.8 TPM
Córtex cerebral
14.0 TPM
Brain Frontal Cortex BA9
13.9 TPM
OUTRAS DOENÇAS (12)
maturity-onset diabetes of the young type 13diabetes mellitus, permanent neonatal 2hyperinsulinemic hypoglycemia, familial, 2diabetes mellitus, transient neonatal, 3
HGNC:6257UniProt:Q14654
HNF4AHepatocyte nuclear factor 4-alphaDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcriptional regulator which controls the expression of hepatic genes during the transition of endodermal cells to hepatic progenitor cells, facilitating the recruitment of RNA pol II to the promoters of target genes (PubMed:30597922). Activates the transcription of CYP2C38 (By similarity). Represses the CLOCK-BMAL1 transcriptional activity and is essential for circadian rhythm maintenance and period regulation in the liver and colon cells (PubMed:30530698)

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
Nuclear Receptor transcription pathwayNephron development
MECANISMO DE DOENÇA

Maturity-onset diabetes of the young 1

A form of diabetes that is characterized by an autosomal dominant mode of inheritance, onset in childhood or early adulthood (usually before 25 years of age), a primary defect in insulin secretion and frequent insulin-independence at the beginning of the disease.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
55.4 TPM
Cólon transverso
33.0 TPM
Intestino delgado
30.7 TPM
Rim - Córtex
11.4 TPM
Pâncreas
5.6 TPM
OUTRAS DOENÇAS (7)
maturity-onset diabetes of the young type 1Fanconi renotubular syndrome 4 with maturity-onset diabetes of the youngmonogenic diabetesatypical Fanconi syndrome-neonatal hyperinsulinism syndrome
HGNC:5024UniProt:P41235
CELBile salt-activated lipaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the hydrolysis of a wide range of substrates including cholesteryl esters, phospholipids, lysophospholipids, di- and tri-acylglycerols, and fatty acid esters of hydroxy fatty acids (FAHFAs) (PubMed:10220579, PubMed:27509211, PubMed:27650499, PubMed:8471055). Preferentially hydrolyzes FAHFAs with the ester bond further away from the carboxylate. Unsaturated FAHFAs are hydrolyzed more quickly than saturated FAHFAs (By similarity). Has an essential role in the complete digestion of dietar

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (1)
Developmental Lineage of Pancreatic Acinar Cells
MECANISMO DE DOENÇA

Maturity-onset diabetes of the young 8 with exocrine dysfunction

An autosomal dominant form of diabetes characterized by a primary defect in insulin secretion, exocrine pancreatic dysfunction, altered pancreatic morphology, recurrent abdominal pain, and fecal elastase deficiency. Disease onset is at less than 25 years of age.

OUTRAS DOENÇAS (2)
maturity-onset diabetes of the young type 8maturity-onset diabetes of the young
HGNC:1848UniProt:P19835
NARS2Asparaginyl-tRNA synthetaseCandidate gene tested inTolerante
FUNÇÃO

Mitochondrial aminoacyl-tRNA synthetase that catalyzes the specific attachment of the asparagine amino acid (aa) to the homologous transfer RNA (tRNA), further participating in protein synthesis (PubMed:25385316). The reaction occurs in a two steps: asparagine is first activated by ATP to form Asn-AMP and then transferred to the acceptor end of tRNA(Asn) (Probable)

LOCALIZAÇÃO

Mitochondrion matrixMitochondrion

VIAS BIOLÓGICAS (1)
Mitochondrial tRNA aminoacylation
MECANISMO DE DOENÇA

Combined oxidative phosphorylation deficiency 24

An autosomal recessive mitochondrial disorder with wide phenotypic variability. Some patients have a milder form affecting only skeletal muscle, whereas others may have a more severe disorder, reminiscent of Alpers syndrome. Alpers syndrome is a progressive neurodegenerative disorder that presents in infancy or early childhood and is characterized by diffuse degeneration of cerebral gray matter.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
24.4 TPM
Ovário
17.6 TPM
Fibroblastos
16.6 TPM
Cervix Endocervix
16.3 TPM
Cervix Ectocervix
15.3 TPM
OUTRAS DOENÇAS (4)
combined oxidative phosphorylation defect type 24hearing loss, autosomal recessive 94DEND syndromehearing loss, autosomal recessive
HGNC:26274UniProt:Q96I59
PDX1Pancreas/duodenum homeobox protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Activates insulin, somatostatin, glucokinase, islet amyloid polypeptide and glucose transporter type 2 gene transcription. Particularly involved in glucose-dependent regulation of insulin gene transcription. As part of a PDX1:PBX1b:MEIS2b complex in pancreatic acinar cells is involved in the transcriptional activation of the ELA1 enhancer; the complex binds to the enhancer B element and cooperates with the transcription factor 1 complex (PTF1) bound to the enhancer A element. Binds preferentiall

LOCALIZAÇÃO

NucleusCytoplasm, cytosol

VIAS BIOLÓGICAS (5)
Regulation of gene expression in beta cellsRegulation of gene expression in early pancreatic precursor cellsDevelopmental Lineage of Multipotent Pancreatic Progenitor CellsDevelopmental Lineage of Pancreatic Ductal CellsDevelopmental Lineage of Pancreatic Acinar Cells
MECANISMO DE DOENÇA

Pancreatic agenesis 1

A disease characterized by isolated hypoplasia or agenesis of the pancreas, pancreatic beta-cell failure resulting in neonatal insulin-dependent diabetes mellitus, and exocrine pancreatic insufficiency.

EXPRESSÃO TECIDUAL(Tecido-específico)
Pâncreas
9.2 TPM
Linfócitos
0.5 TPM
Testículo
0.2 TPM
Fígado
0.2 TPM
Estômago
0.1 TPM
OUTRAS DOENÇAS (6)
maturity-onset diabetes of the young type 4pancreatic agenesis 1pancreatic agenesismaturity-onset diabetes of the young
HGNC:6107UniProt:P52945
ZFP57Zinc finger protein 57 homologDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Transcription regulator required to maintain maternal and paternal gene imprinting, a process by which gene expression is restricted in a parent of origin-specific manner by epigenetic modification of genomic DNA and chromatin, including DNA methylation. Acts by controlling DNA methylation during the earliest multicellular stages of development at multiple imprinting control regions (ICRs) (PubMed:18622393, PubMed:30602440). Acts together with ZNF445, but ZNF445 seems to be the major factor in h

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Diabetes mellitus, transient neonatal, 1

An autosomal dominant form of diabetes mellitus defined by the onset of mild-to-severe hyperglycemia within the first month of life. In about half of the neonates, diabetes is transient and resolves at a median age of 3 months, whereas the rest have a permanent form of diabetes.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Spinal cord cervical c-1
17.7 TPM
Substância negra
6.5 TPM
Hipocampo
4.5 TPM
Brain Putamen basal ganglia
3.6 TPM
Cérebro - Amígdala
3.3 TPM
OUTRAS DOENÇAS (1)
diabetes mellitus, transient neonatal, 1
HGNC:18791UniProt:Q9NU63
KLF11Krueppel-like factor 11Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Transcription factor (PubMed:10207080, PubMed:9748269). Activates the epsilon- and gamma-globin gene promoters and, to a much lower degree, the beta-globin gene and represses promoters containing SP1-like binding inhibiting cell growth (PubMed:10207080, PubMed:16131492, PubMed:9748269). Represses transcription of SMAD7 which enhances TGF-beta signaling (By similarity). Induces apoptosis (By similarity)

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Maturity-onset diabetes of the young 7

A form of diabetes that is characterized by an autosomal dominant mode of inheritance, onset in childhood or early adulthood (usually before 25 years of age), a primary defect in insulin secretion and frequent insulin-independence at the beginning of the disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
43.6 TPM
Tecido adiposo
42.3 TPM
Adipose Visceral Omentum
38.4 TPM
Skin Not Sun Exposed Suprapubic
35.0 TPM
Mama
34.6 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (2)
maturity-onset diabetes of the young type 7maturity-onset diabetes of the young
HGNC:11811UniProt:O14901
APPL1DCC-interacting protein 13-alphaCandidate gene tested inRestrito
FUNÇÃO

Multifunctional adapter protein that binds to various membrane receptors, nuclear factors and signaling proteins to regulate many processes, such as cell proliferation, immune response, endosomal trafficking and cell metabolism (PubMed:10490823, PubMed:15016378, PubMed:19661063, PubMed:26073777, PubMed:26583432). Regulates signaling pathway leading to cell proliferation through interaction with RAB5A and subunits of the NuRD/MeCP1 complex (PubMed:15016378). Functions as a positive regulator of i

LOCALIZAÇÃO

Early endosome membraneNucleusCytoplasmEndosomeCell projection, ruffleCytoplasmic vesicle, phagosome

VIAS BIOLÓGICAS (1)
Caspase activation via Dependence Receptors in the absence of ligand
MECANISMO DE DOENÇA

Maturity-onset diabetes of the young 14

A form of diabetes that is characterized by an autosomal dominant mode of inheritance, onset in childhood or early adulthood (usually before 25 years of age), a primary defect in insulin secretion and frequent insulin-independence at the beginning of the disease.

OUTRAS DOENÇAS (2)
maturity-onset diabetes of the youngmaturity-onset diabetes of the young type 14
HGNC:24035UniProt:Q9UKG1
GLIS3Zinc finger protein GLIS3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Acts both as a repressor and an activator of transcription. Binds to the consensus sequence 5'-GACCACCCAC-3' (By similarity)

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Diabetes mellitus, neonatal, with congenital hypothyroidism

A syndrome of neonatal diabetes syndrome associated with congenital hypothyroidism, congenital glaucoma, hepatic fibrosis and polycystic kidneys.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
13.1 TPM
Ovário
9.0 TPM
Cervix Endocervix
8.5 TPM
Fibroblastos
6.8 TPM
Rim - Medula
6.4 TPM
OUTRAS DOENÇAS (1)
neonatal diabetes mellitus with congenital hypothyroidism
HGNC:28510UniProt:Q8NEA6
PAX4Paired box protein Pax-4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays an important role in the differentiation and development of pancreatic islet beta cells. Transcriptional repressor that binds to a common element in the glucagon, insulin and somatostatin promoters. Competes with PAX6 for this same promoter binding site. Isoform 2 appears to be a dominant negative form antagonizing PAX4 transcriptional activity

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells
MECANISMO DE DOENÇA

Type 2 diabetes mellitus

A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.3 TPM
Intestino delgado
0.3 TPM
Cólon transverso
0.2 TPM
Pâncreas
0.0 TPM
Linfócitos
0.0 TPM
OUTRAS DOENÇAS (4)
maturity-onset diabetes of the young type 9type 2 diabetes mellitusmaturity-onset diabetes of the youngdiabetes mellitus, ketosis-prone
HGNC:8618UniProt:O43316
HNF1BHepatocyte nuclear factor 1-betaDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcription factor that binds to the inverted palindrome 5'-GTTAATNATTAAC-3' (PubMed:17924661, PubMed:7900999). Binds to the FPC element in the cAMP regulatory unit of the PLAU gene (By similarity). Transcriptional activity is increased by coactivator PCBD1 (PubMed:24204001)

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (6)
Nephron developmentRegulation of gene expression in early pancreatic precursor cellsRegulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cellsDevelopmental Lineage of Multipotent Pancreatic Progenitor CellsDevelopmental Lineage of Pancreatic Ductal Cells
MECANISMO DE DOENÇA

Renal cysts and diabetes syndrome

An autosomal dominant disorder comprising non-diabetic renal disease resulting from abnormal renal development, and diabetes, which in some cases occurs earlier than age 25 years and is thus consistent with a diagnosis of maturity-onset diabetes of the young (MODY5). The renal disease is highly variable and includes renal cysts, glomerular tufts, aberrant nephrogenesis, primitive tubules, irregular collecting systems, oligomeganephronia, enlarged renal pelves, abnormal calyces, small kidney, single kidney, horseshoe kidney, and hyperuricemic nephropathy. Affected individuals may also have abnormalities of the genital tract.

EXPRESSÃO TECIDUAL(Tecido-específico)
Rim - Medula
90.4 TPM
Rim - Córtex
53.5 TPM
Linfócitos
43.7 TPM
Pâncreas
23.0 TPM
Cólon transverso
14.9 TPM
OUTRAS DOENÇAS (11)
type 2 diabetes mellitusrenal cysts and diabetes syndromechromosome 17q12 deletion syndromerenal dysplasia, unilateral
HGNC:11630UniProt:P35680
PTF1APancreas transcription factor 1 subunit alphaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Transcription factor implicated in the cell fate determination in various organs. Binds to the E-box consensus sequence 5'-CANNTG-3'. Plays a role in early and late pancreas development and differentiation. Important for determining whether cells allocated to the pancreatic buds continue towards pancreatic organogenesis or revert back to duodenal fates. May be involved in the maintenance of exocrine pancreas-specific gene expression including ELA1 and amylase. Required for the formation of pancr

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (2)
Regulation of gene expression in early pancreatic precursor cellsDevelopmental Lineage of Pancreatic Acinar Cells
MECANISMO DE DOENÇA

Pancreatic and cerebellar agenesis

A disease characterized by neonatal diabetes mellitus, cerebellar agenesis or hypoplasia, severe intrauterine growth retardation, the presence of very little subcutaneous fat, and dysmorphic facial features.

EXPRESSÃO TECIDUAL(Tecido-específico)
Pâncreas
30.3 TPM
Testículo
2.3 TPM
Estômago
0.8 TPM
Córtex cerebral
0.4 TPM
Brain Frontal Cortex BA9
0.4 TPM
OUTRAS DOENÇAS (3)
pancreatic agenesis 2permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndromepancreatic agenesis
HGNC:23734UniProt:Q7RTS3
INSInsulinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (2)
Insulin receptor recyclingSignaling by Insulin receptor
MECANISMO DE DOENÇA

Hyperproinsulinemia

An autosomal dominant condition characterized by elevated levels of serum proinsulin-like material.

EXPRESSÃO TECIDUAL(Tecido-específico)
Pâncreas
2325.3 TPM
Glândula adrenal
0.5 TPM
Cervix Ectocervix
0.5 TPM
Substância negra
0.4 TPM
Baço
0.3 TPM
OUTRAS DOENÇAS (6)
maturity-onset diabetes of the young type 10diabetes mellitus, permanent neonatal 4hyperproinsulinemiatype 1 diabetes mellitus 2
HGNC:6081UniProt:P01308
NEUROD1Neurogenic differentiation factor 1Disease-causing germline mutation(s) inModerado
FUNÇÃO

Acts as a transcriptional activator: mediates transcriptional activation by binding to E box-containing promoter consensus core sequences 5'-CANNTG-3'. Associates with the p300/CBP transcription coactivator complex to stimulate transcription of the secretin gene as well as the gene encoding the cyclin-dependent kinase inhibitor CDKN1A. Contributes to the regulation of several cell differentiation pathways, like those that promote the formation of early retinal ganglion cells, inner ear sensory n

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (2)
Regulation of gene expression in beta cellsRegulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells
MECANISMO DE DOENÇA

Maturity-onset diabetes of the young 6

A form of diabetes that is characterized by an autosomal dominant mode of inheritance, onset in childhood or early adulthood (usually before 25 years of age), a primary defect in insulin secretion and frequent insulin-independence at the beginning of the disease.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
306.4 TPM
Cerebelo
215.4 TPM
Hipocampo
4.2 TPM
Brain Frontal Cortex BA9
3.6 TPM
Córtex cerebral
3.4 TPM
OUTRAS DOENÇAS (3)
maturity-onset diabetes of the young type 6maturity-onset diabetes of the youngtype 2 diabetes mellitus
HGNC:7762UniProt:Q13562
BLKTyrosine-protein kinase BlkDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Non-receptor tyrosine kinase involved in B-lymphocyte development, differentiation and signaling (By similarity). B-cell receptor (BCR) signaling requires a tight regulation of several protein tyrosine kinases and phosphatases, and associated coreceptors (By similarity). Binding of antigen to the B-cell antigen receptor (BCR) triggers signaling that ultimately leads to B-cell activation (By similarity). Signaling through BLK plays an important role in transmitting signals through surface immunog

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
RUNX1 regulates transcription of genes involved in BCR signaling
MECANISMO DE DOENÇA

Maturity-onset diabetes of the young 11

A form of diabetes that is characterized by an autosomal dominant mode of inheritance, onset in childhood or early adulthood (usually before 25 years of age), a primary defect in insulin secretion and frequent insulin-independence at the beginning of the disease.

OUTRAS DOENÇAS (3)
maturity-onset diabetes of the young type 11systemic lupus erythematosusmaturity-onset diabetes of the young
HGNC:1057UniProt:P51451
PLAGL1Zinc finger protein PLAGL1Candidate gene tested inRestrito
FUNÇÃO

Acts as a transcriptional activator (PubMed:9722527). Involved in the transcriptional regulation of type 1 receptor for pituitary adenylate cyclase-activating polypeptide

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
MECANISMO DE DOENÇA

Diabetes mellitus, transient neonatal, 1

An autosomal dominant form of diabetes mellitus defined by the onset of mild-to-severe hyperglycemia within the first month of life. In about half of the neonates, diabetes is transient and resolves at a median age of 3 months, whereas the rest have a permanent form of diabetes.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
65.9 TPM
Aorta
52.5 TPM
Glândula adrenal
41.8 TPM
Skin Not Sun Exposed Suprapubic
36.5 TPM
Ovário
33.6 TPM
OUTRAS DOENÇAS (2)
paternal uniparental disomy of chromosome 6diabetes mellitus, transient neonatal, 1
HGNC:9046UniProt:Q9UM63
ABCC8ATP-binding cassette sub-family C member 8Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Regulator subunit of pancreatic ATP-sensitive potassium channel (KATP), playing a major role in the regulation of insulin release. In pancreatic cells, it forms KATP channels with KCNJ11; KCNJ11 forms the channel pore while ABCC8 is required for activation and regulation

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Regulation of insulin secretionATP sensitive Potassium channels
MECANISMO DE DOENÇA

Leucine-induced hypoglycemia

Rare cause of hypoglycemia and is described as a condition in which symptomatic hypoglycemia is provoked by high protein feedings. Hypoglycemia is also elicited by administration of oral or intravenous infusions of a single amino acid, leucine.

OUTRAS DOENÇAS (12)
hyperinsulinemic hypoglycemia, familial, 1diabetes mellitus, transient neonatal, 2diabetes mellitus, permanent neonatal 3hypoglycemia, leucine-induced
HGNC:59UniProt:Q09428
STAT3Signal transducer and activator of transcription 3Candidate gene tested inAltamente restrito
FUNÇÃO

Signal transducer and transcription activator that mediates cellular responses to interleukins, KITLG/SCF, LEP and other growth factors (PubMed:10688651, PubMed:12359225, PubMed:12873986, PubMed:15194700, PubMed:15653507, PubMed:16285960, PubMed:17344214, PubMed:18242580, PubMed:18782771, PubMed:22306293, PubMed:23084476, PubMed:28262505, PubMed:32929201, PubMed:38404237). Once activated, recruits coactivators, such as NCOA1 or MED1, to the promoter region of the target gene (PubMed:15653507, Pu

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (10)
Interleukin-20 family signalingDownstream signal transductionInterleukin-15 signalingSignaling by SCF-KITInterleukin-9 signaling
MECANISMO DE DOENÇA

Hyper-IgE syndrome 1, autosomal dominant, with recurrent infections

A rare disorder of immunity and connective tissue characterized by immunodeficiency, chronic eosinophilia, distinctive coarse facial appearance, abnormal dentition, hyperextensibility of the joints, and bone fractures.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
173.0 TPM
Artéria tibial
145.7 TPM
Aorta
144.8 TPM
Adipose Visceral Omentum
140.2 TPM
Fallopian Tube
136.9 TPM
OUTRAS DOENÇAS (7)
hyper-IgE recurrent infection syndrome 1, autosomal dominantSTAT3-related early-onset multisystem autoimmune diseasebreast implant-associated anaplastic large cell lymphomaacute promyelocytic leukemia
HGNC:11364UniProt:P40763
HYMAICandidate gene tested inDesconhecido
LOCALIZAÇÃO

OUTRAS DOENÇAS (2)
diabetes mellitus, transient neonatal, 1paternal uniparental disomy of chromosome 6
HGNC:5326
C12orf43Protein CUSTOSDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in the regulation of Wnt signaling pathway during early development

LOCALIZAÇÃO

Nucleus envelope

INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
monogenic diabetes
HGNC:HGNC:25719UniProt:Q96C57

Variantes genéticas (ClinVar)

1,682 variantes patogênicas registradas no ClinVar.

🧬 GCK: NM_000162.5(GCK):c.45+1G>A ()
🧬 GCK: NM_000162.5(GCK):c.271G>T (p.Val91Leu) ()
🧬 GCK: NM_000162.5(GCK):c.329T>A (p.Ile110Asn) ()
🧬 GCK: NM_000162.5(GCK):c.512T>G (p.Phe171Cys) ()
🧬 GCK: NM_000162.5(GCK):c.549del (p.Leu184fs) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

65 vias biológicas associadas aos genes desta condição.

Defective GCK causes maturity-onset diabetes of the young 2 (MODY2) Defective HK1 causes hexokinase deficiency (HK deficiency) FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes Regulation of gene expression in beta cells ATP sensitive Potassium channels ABC-family proteins mediated transport Regulation of insulin secretion Ion homeostasis Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome Defective ABCC8 can cause hypo- and hyper-glycemias Nuclear Receptor transcription pathway Nephron development Digestion of dietary lipid Developmental Lineage of Pancreatic Acinar Cells Mitochondrial tRNA aminoacylation Regulation of gene expression in early pancreatic precursor cells Developmental Lineage of Pancreatic Ductal Cells Developmental Lineage of Multipotent Pancreatic Progenitor Cells Caspase activation via Dependence Receptors in the absence of ligand Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells Insulin processing Synthesis, secretion, and deacylation of Ghrelin COPI-mediated anterograde transport PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling IRS activation Signal attenuation Insulin receptor signalling cascade Signaling by Insulin receptor Insulin receptor recycling NPAS4 regulates expression of target genes Amyloid fiber formation RUNX1 regulates transcription of genes involved in BCR signaling Antigen activates B Cell Receptor (BCR) leading to generation of second messengers TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain Interleukin-6 signaling BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members Interleukin-7 signaling Signaling by SCF-KIT Signaling by cytosolic FGFR1 fusion mutants Downstream signal transduction Signalling to STAT3 Signaling by ALK Senescence-Associated Secretory Phenotype (SASP) Signaling by Leptin POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation Association of TriC/CCT with target proteins during biosynthesis Transcriptional regulation of pluripotent stem cells Interleukin-10 signaling Interleukin-4 and Interleukin-13 signaling PTK6 Activates STAT3 Interleukin-20 family signaling MET activates STAT3 Interleukin-15 signaling Interleukin-35 Signalling Interleukin-9 signaling Interleukin-37 signaling Interleukin-23 signaling Interleukin-27 signaling Interleukin-21 signaling Transcriptional regulation of granulopoiesis Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants Signaling by PDGFRA extracellular domain mutants Signaling by CSF3 (G-CSF)

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 21
·Pré-clínico4
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 5 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Diabetes mellitus genéticos raros

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

4 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

0 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Clinical Characterization of Atypical Diabetes: Insights from the GENEPEDIAB Study into the Spectrum Between Type 1 and Monogenic Diabetes.

Cells2026 Mar 07

Type 1 diabetes (T1D) shares clinical characteristics with other forms of diabetes, particularly monogenic diabetes such as maturity-onset diabetes of the young (MODY). Differential diagnosis is complicated by the existence of intermediate phenotypes. We aimed to delineate the phenotypic continuum between T1D and monogenic diabetes. The multicentric GENEPEDIAB study included patients aged 6 months to 18 years diagnosed with diabetes and treated for either T1D or monogenic diabetes. Analyses comprised glycemic variability, continuous glucose monitoring metrics, application of the DIAMODIA criteria, and genetic investigations. A gradient was observed across T1D, atypical diabetes (Adia), and MODY cohorts for several glycemic parameters. T1D patients exhibited values furthest from treatment targets, whereas MODY patients showed better glycemic control. Stratification of the Adia cohort according to the number of positive DIAMODIA criteria further supported this trend, as demonstrated by glycemic measures and multiple correspondence analysis. Genetic analyses did not identify a uniform causative variant in the Adia cohort; however, several rare variants, including variants of uncertain significance and likely pathogenic variants in diabetes-related genes, were detected. These findings showed, in our specific cohort of pediatric patients, the existence of a phenotypic gradient between T1D and monogenic diabetes, with atypical diabetes occupying an intermediate position, including when stratified by DIAMODIA criteria.

#2

Original research: Amplification of genetic and metabolic factors in alpha-1 antitrypsin deficiency.

Hepatology (Baltimore, Md.)2026 Mar 11

Severe (Pi*ZZ) and heterozygous (Pi*MZ) alpha-1 antitrypsin deficiency (AATD) confer increased liver- and lung-related mortality, but the phenotype is highly variable. We aimed to evaluate the impact of obesity and diabetes mellitus on individuals with/without AATD. Cohort 1 prospectively recruited 1678 Pi*ZZ adults from an international initiative with a systematic liver assessment. 983 participants had a longitudinal follow-up. The data were compared to 16,768 Pi*MZ and 415,208 non-AATD individuals from the United Kingdom Biobank (cohort 2). Findings were ascertained by multivariable adjustment and propensity score matching. At baseline, diabetes was present in 52 (3%), overweight (BMI 25.0-29.9 kg/m2) in 540 (52%) and obesity (BMI≥30 kg/m2) in 266 (32%) Pi*ZZ adults. Pi*ZZ individuals with diabetes showed higher transaminases and surrogates of advanced liver fibrosis (APRI≥1.0, LSM≥15 kPa) were four to six times more common (adjusted Odds Ratio (aOR) 5.7/4.3, p<0.01). Elevated transaminases were rare among lean Pi*ZZ subjects, but more common in overweight (aOR 1.5/2.0) and obese Pi*ZZ participants (aOR 2.1/2.9). APRI≥1.0 was more than four times elevated in obese vs. lean Pi*ZZ individuals (aOR 4.1, p<0.001). During a median follow-up of 4.2 years, 54 Pi*ZZ participants experienced a hepatic and 64 a pulmonary endpoint. While Pi*ZZ participants with diabetes/obesity had an increased risk of hepatic endpoints (aHR 6.03/3.38, p<0.001) compared with non-diabetic/lean Pi*ZZ subjects, overweight was associated with a decreased risk of pulmonary endpoints (aHR 0.45, p=0.004). Our data demonstrate the interaction between genetic and metabolic risk factors in AATD and provide evidence for patient management.

#3

Novel Homozygous Variants in CIDEC and WRN in a Young Female with Lipodystrophy and Thyroid Cancer.

International journal of molecular sciences2026 Jan 08

Autosomal recessive familial partial lipodystrophy type 5 (FPLD5) due to a homozygous NP_001186481.1; p.E186* CIDEC variant has previously been reported in a 19-year-old female with diabetes mellitus, hypertriglyceridemia, and hepatic steatosis. Now, we report an 18-year-old Hispanic female who presented with FPL, along with hirsutism, acanthosis nigricans, and marked insulin resistance, and was found to have an extremely rare homozygous variant in CIDEC (NM_001199623.2:c.224G>T; NP_001186552.1; p.Ser75Ile) by whole exome sequencing. She also harbored a novel homozygous variant in WRN (NM_000553.4:c.1856T>G; NP_000544; p.Leu619Arg). Both serine 75 of the CIDEC protein and leucine 619 of the WRN protein were well conserved across species. She developed an invasive papillary thyroid carcinoma at the age of 17 years. Our report confirms the previously reported association of the biallelic CIDEC variant with the FPL phenotype and also highlights the extremely rare possibility of co-occurrence of FPLD5 with thyroid cancer, a clinical feature of Werner syndrome. Thus, our patient may not only need surveillance for the metabolic complications of FPLD5, such as diabetes, hypertriglyceridemia, and hepatic steatosis, but also for WRN-associated neoplasms and features of premature aging.

#4

Skeletal Muscle HSF1 Alleviates Age-Associated Sarcopenia and Mitochondrial Function Decline via SIRT3-PGC1α Axis.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)2026 Feb

Age-related sarcopenia, characterized by progressive loss of skeletal muscle mass and strength, impacts metabolic health and quality of life in the elderly. Heat shock factor 1 (HSF1) is a transcription factor that orchestrates cellular responses to various stresses, while its role in sarcopenia remains unknown. Here, HSF1 mRNA expression was decreased in muscles of aged mice and humans, correlating negatively with the atrophic gene and positively with the mitochondrial gene. Aged HSF1 muscle-specific knockout mice exhibited severe muscle atrophy and reduced endurance capacity, partially due to smaller fast fibers and mitochondrial dysfunction in slow fibers, as well as impaired systemic metabolic performance. In contrast, HSF1 overexpression in skeletal muscle improved these functions. Mechanistically, via RNA sequencing (RNA-seq) and chromatin immunoprecipitation sequencing (ChIP-seq), it is revealed that HSF1 transcriptionally activated Sirtuin3 (SIRT3) for the deacetylation of both PGC1α1 and PGC1α4 isoforms of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α), in skeletal muscle, enhancing mitochondrial function and muscle hypertrophy in vivo and in vitro, and inducing fibronectin type III domain-containing protein 5 (FNDC5)/Irisin for tissue crosstalk. Thus, HSF1 regulates skeletal muscle functions and systemic energy homeostasis via the SIRT3-PGC1α axis, representing a potential therapeutic target for sarcopenia and metabolic disorders.

#5

Transgenic overexpression of miR-486 and sAnk1.5 does not alter glucose handling in mice.

Biochimica et biophysica acta. Molecular cell research2026 Jan

Recent studies have shown that the C allele of SNP rs508419 is associated with susceptibility to Type 2 diabetes (T2D). This SNP lies within the muscle-specific P2 promoter of human ANK1, which drives transcription of the sAnk1.5 isoform and miR-486. The C allele increases P2 promoter activity, resulting to higher levels of sAnk1.5 transcript and protein in striated muscles. We now present the first evidence that in skeletal muscle of individuals homozygous for the rs508419 C allele, also the hsa-miR-486-5p is transcribed at higher levels. This raises the question of whether T2D susceptibility may be associated with simultaneous overexpression of miR-486-5p and sAnk1.5. To test this hypothesis, we generated and characterized double transgenic (D-Tg) mice that selectively overexpress both mmu-miR-486-5p and sAnk1.5 in skeletal muscle tissue. Analysis of sAnk1.5 and miR-486-5p expression in D-Tg mouse showed that despite both transgenes were significantly upregulated, a discrepancy between sAnk1.5 mRNA and protein levels was observed, suggesting that sAnk1.5 protein levels are further regulated by post-translational mechanism. D-Tg mice were monitored from 2 to 12 months of age to assess body weight, fat and lean mass, blood glucose levels under fasting conditions, as well as during intraperitoneal glucose tolerance tests and insulin tolerance tests, performed under either standard or high fat diet conditions. No differences were observed between D-Tg and age-matched wild type control mice for any of the parameters tested, indicating that the link between rs508419 and susceptibility to T2D cannot be ascribed to increased expression of miR-486-5p and sAnk1.5 in skeletal muscle.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 200

2026

Epidemiology, Comorbidities, and Healthcare Costs of Prader-Willi Syndrome in South Korea Using the Korean National Health Insurance Service Database.

Journal of obesity &amp; metabolic syndrome
2026

Optic Atrophy in Wolfram Syndrome Type 1: A Retrospective Analysis of Visual Outcomes and Biomarker Correlates.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2026

Lipodystrophies in Clinical Practice: A Case Series From a Local Health Unit in Portugal.

Cureus
2026

Age- and diet-dependent progression of retinal microvascular injury in GCK-MODY under metabolic stress.

Frontiers in endocrinology
2026

Diverse and rare candidate MODY gene variants were identified in one-fifth of a Bangladeshi cohort with nonobese, nonautoimmune youth-onset diabetes.

Scientific reports
2026

Berardinelli-Seip syndrome.

Endokrynologia Polska
2026

Thiamine-responsive megaloblastic anemia syndrome with novel compound heterozygous SLC19A2 mutations and thrombotic events: a case report.

Journal of medical case reports
2026

A type 2 diabetes patient with three years of persistent abdominal pain: the culprit was variegate porphyria-a case report.

Frontiers in endocrinology
2026

Clinical Characterization of Atypical Diabetes: Insights from the GENEPEDIAB Study into the Spectrum Between Type 1 and Monogenic Diabetes.

Cells
2026

Original research: Amplification of genetic and metabolic factors in alpha-1 antitrypsin deficiency.

Hepatology (Baltimore, Md.)
2025

Pediatric Hepatocyte Nuclear Factor 1B (HNF1B) Disease: Diabetes and Endocrine Manifestations.

Pediatric diabetes
2026

Neonatal Diabetes Mellitus Due to Homozygous ZNF808 Mutation Associated With Skeletal Anomalies: A Novel Presentation of Pancreatic Agenesis-3.

Cureus
2026

Adult-Onset Diabetes and Liver Fibrosis as Diagnostic Clues to Alström Syndrome: A Case Report.

Cureus
2026

[Biobanking in internal medicine : Structures, opportunities and cultural responsibility].

Innere Medizin (Heidelberg, Germany)
2026

Monogenic Neonatal Diabetes: Clinical Presentations, Genetic Findings, and Response to Therapy in a Retrospective Case Series.

Cureus
2026

A Novel Autoimmune Presentation of Wiskott-Aldrich Syndrome: Type 1 Diabetes.

Immunity, inflammation and disease
2026

Coexistence of Friedreich's Ataxia and Esophageal Cancer: A Case Report.

Clinical case reports
2026

Transient Neonatal Diabetes Mellitus Potentially Associated With a Novel Homozygous MS4A6A Gene Variant: A Case Report.

Cureus
2026

Routine Fundoscopy Uncovering Wolfram Syndrome in a Diabetic Patient: A Case Report.

Cureus
2026

Interference of Hb J-Sardegna on HbA1c Quantification in a Diabetic Patient.

Clinical laboratory
2026

Genetic Insights on Hypertriglyceridaemia-Induced Acute Pancreatitis in Pregnancy: A Case Series and Literature Review.

Case reports in endocrinology
2026

Two Distinct Endocrine Conditions in a Single Pediatric Patient: Congenital Adrenal Hyperplasia and Type 1 Diabetes Mellitus.

Cureus
2026

Novel variation in the CEL gene causing impaired fasting glucose in a Chinese pediatric patient: case report and literature review.

Frontiers in endocrinology
2026

Pediatric IPEX-Associated Dermatitis Responds To Dupilumab: Evidence from Skin Transcriptomics and Immune Profiling.

Journal of clinical immunology
2026

Prevalence, risk factors and management of bone complications in Cushing's syndrome across Europe. Data from the European Registry on Cushing's syndrome (ERCUSYN).

Annales d'endocrinologie
2026

Neonatal Diabetes in Ireland over the Past 19 Years: Clinical Presentation, Management, Genetics, and Outcomes.

Hormone research in paediatrics
2026

Type 2 Diabetes in a Portuguese Adolescent With Hijazi-Reis Syndrome.

Cureus
2026

Childhood thiamine-responsive megaloblastic anemia and diabetes: a case series highlighting early diagnosis and management.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2025

Streptococcus pyogenes and EBV coinfection in severe adult meningoencephalitis: a rare diagnosis in a diabetic patient.

Frontiers in cellular and infection microbiology
2025

Increased epicardial adipose tissue is part of the phenotype of LMNA-associated partial lipodystrophy and could contribute to increased cardiovascular risk.

Diabetes &amp; metabolism
2026

The Genetic Landscape and Precision Medicine in Neonatal Diabetes Mellitus: From Molecular Mechanisms to Clinical Management.

Current issues in molecular biology
2025

A novel heterozygous WFS1 variant of uncertain significance in a patient with early-onset diabetes: a case report.

Frontiers in endocrinology
2026

Unveiling a Novel MT-TS1 m.7479G>A in Mitochondrial Diabetes: The Critical Role of mtDNA Sequencing in Atypical Cases.

JCEM case reports
2026

Clinical spectrum of extreme insulin resistance syndromes treated with rhIGF-1: a single centre experience.

The Journal of clinical endocrinology and metabolism
2026

Novel Homozygous Variants in CIDEC and WRN in a Young Female with Lipodystrophy and Thyroid Cancer.

International journal of molecular sciences
2026

Cohen syndrome with novel VPS13B variants presenting as early-onset diabetes: a case report.

Acta diabetologica
2026

Study of the ovarian function and gyneco-obstetrical profile of patients with an HNF1B abnormality.

European journal of obstetrics, gynecology, and reproductive biology
2026

Age at type 2 diabetes onset and risk of dementia: The modifying role of genetic susceptibility and mitochondrial function.

The journal of nutrition, health &amp; aging
2026

Epimutation analysis reveals involvement of SLIT2/ROBO signaling pathway in painful diabetic neuropathy.

Human genomics
2026

Improvement of severe hypertriglyceridemia in atypical subtype 4 partial lipodystrophy with volanesorsen.

Journal of clinical lipidology
2026

Targeted analysis of whole exome sequencing in Thai patients with neonatal diabetes.

Human genetics
2025

Genetic Characterization of MODY in Iranian Families Using Multigenerational-Based Whole-Exome Sequencing Approach.

Journal of diabetes research
2026

A new form of diabetes caused by INS mutations defined by zygosity, stem cell and population data.

EMBO molecular medicine
2025

Clinical and genetic characteristics of young-onset diabetes with concurrent mitochondrial m.3243A>G and CEL gene mutations: A case report.

World journal of diabetes
2025

dentification and characterization of novel PAX4 variants in patients with suspected MODY9.

BMJ open diabetes research &amp; care
2026

Approach to the Patient: Mitochondrial Diabetes: Contemporary Cases and a Precision Medicine Approach.

The Journal of clinical endocrinology and metabolism
2025

Diabetes mellitus in SHORT syndrome managed with multi-agent oral therapies: a case report and literature review.

Therapeutic advances in endocrinology and metabolism
2025

Optic Atrophy Predominant WFS1 Disorder-A Case-Control Study.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2026

Skeletal Muscle HSF1 Alleviates Age-Associated Sarcopenia and Mitochondrial Function Decline via SIRT3-PGC1α Axis.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2026

Duration-dependent alterations of lipid profiles and microvascular complications in GCK-MODY.

Biochimica et biophysica acta. Molecular basis of disease
2025

Exome Sequencing of a Type 1 Diabetes Mellitus Family Exposes Both Common and Individualized Rare Variants Contributing to Pathogenesis.

Journal of diabetes research
2025

Effect of empagliflozin on human primary cardiomyocytes in a chemically induced hypoxia by CoCl2.

Physiological reports
2025

Revealing Monogenic Diabetes: Clinical and Genetic Features of Pediatric MODY Cases in Türkiye: Single Center Experience.

Pediatric diabetes
2025

A Novel EIF2AK3 Variant Causing Wolcott-Rallison Syndrome With Early Neonatal Diabetic Ketoacidosis as Initial Presentation: A Case Report.

Clinical case reports
2025

Recommendations for recognizing and diagnosing Acute Hepatic Porphyria in atypical patient populations.

Orphanet journal of rare diseases
2025

Expression and functional diversity of the glucagon-like peptide-1 receptor across tumor types.

Discover oncology
2025

Trends and clinical features of childhood diabetes subgroups: 28 years of single center experience.

The Turkish journal of pediatrics
2025

Multi-matrix metabolomics in rare monogenic diabetes syndromes: Analysis of oral fluids and serum in carriers of pathogenic variants in the ALMS1/BBS genes.

Computational and structural biotechnology journal
2025

Maturity-Onset Diabetes of the Young (MODY) Presenting With a Diabetic Foot Ulcer: A Case Report.

Cureus
2025

A Rare Case of Wolfram Syndrome in a 27-Year-Old Male From Nepal.

Cureus
2025

Genetic Pleiotropy and Causal Pathways Linking Glycemic Traits to Asthma: An Integrated Proteogenomic Investigation.

Children (Basel, Switzerland)
2025

Surfactant Protein D Mediates the Association Between Smoking and Type 2 Diabetes Mellitus Incidence in the Spanish Adult Population: [email protected] Study.

Journal of xenobiotics
2025

Novel Kruppel-like factor 11 variant of maturity-onset diabetes of the young type 7: A case report.

World journal of diabetes
2026

Ginsenoside Rh2 mitigates hepatic gluconeogenesis by regulating Akt/FoxO1 pathway in type 2 diabetic mice.

International immunopharmacology
2026

Characterization of monogenic diabetes among Sudanese children: a multi-center experience from a population with high consanguinity.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2026

Exercise and functional integrity in non-disease and disease states during human ageing: the relevance of VO2max.

Free radical biology &amp; medicine
2026

Pancreatic volume and immune biomarkers predict checkpoint inhibitor-associated autoimmune diabetes in humans.

The Journal of clinical investigation
2026

Transgenic overexpression of miR-486 and sAnk1.5 does not alter glucose handling in mice.

Biochimica et biophysica acta. Molecular cell research
2025

Stage 1 type 1 diabetes memory B lymphocytes transcriptionally differ from healthy controls and harbor insulin-binding specificities.

ImmunoHorizons
2025

Polygenic risk score and cluster-based analysis suggests links between type 2 diabetes and vascular dementia in the KARE study.

Nature communications
2025

Expanding the spectrum of white matter abnormalities in Wolfram syndrome: a retrospective review.

Frontiers in neurology
2025

A rare case of H syndrome with severe multisystem involvement: Clinical challenges in low-resource healthcare settings.

The Journal of international medical research
2025

Coincidence of Autoimmune Diabetes Mellitus and Familial Partial Lipodystrophy.

JCEM case reports
2025

Rogers Syndrome and Callosal Disconnection in the Setting of Moyamoya Disease.

Cureus
2026

Incidence and synergistic Association of Type 2 diabetes and apolipoprotein E epsilon 4 with dementia risk in the Kunshan aging research with E-health cohort study.

Preventive medicine
2026

PDX-1 related diabetes: a case series of two families highlighting challenges in MODY diagnosis.

Acta diabetologica
2025

MODY PDX1P33T: a mouse model reveals phenotypic divergence from human disease.

Frontiers in endocrinology
2025

18p Deletion Syndrome Associated with Type 1 Diabetes and Hashimoto's Thyroiditis: A Case Report on Autoimmune Disorders and Genetic Factors.

Journal of clinical research in pediatric endocrinology
2026

Melanoma of the Choroid and Ciliary Body in Children: Remission of Metastatic Melanoma of the Choroid After Treatment With Chemotherapy and Immune Checkpoint Inhibition.

Pediatric blood &amp; cancer
2026

Decoding VEXAS syndrome: emerging insights into pathogenesis and clinical management.

Current opinion in rheumatology
2025

Case Report: When genetic diagnosis comes late: lessons from a DEND syndrome patient successfully transitioned to sulfonylurea.

Frontiers in clinical diabetes and healthcare
2025

Discovery of obesity genes through cross-ancestry analysis.

Nature communications
2025

Coexistence of T1DM and GCK-MODY: Case Report and Literature Review.

Journal of clinical research in pediatric endocrinology
2025

Synergistic target network construction and dynamic simulation analysis based on a prospective systems pharmacology strategy.

Medicine
2025

Time-resolved Mendelian randomization detects substantial variation in the detrimental effect of obesity throughout life.

Science advances
2025

ITCH Deficiency Causing Immunodeficiency and Immune Dysregulation.

Pediatrics
2025

Exome and Genome Sequencing Reveals Novel Variants for Severe Diabetic Retinopathy in Type 1 Diabetes.

Investigative ophthalmology &amp; visual science
2025

A case report of co-isolation of Lactobacillus delbrueckii and Candida albicans from blood cultures of an elderly woman with diabetes mellitus.

The new microbiologica
2025

Association of matrix metalloproteinase-10 levels and genetic variant rs17860955 with severe vascular complications in patients with type 1 diabetes: prospective cohort.

Journal of diabetes and its complications
2025

Beyond the Classical Triad: Atypical Presentations and Regulatory T Cell Phenotyping in a Cohort of IPEX Patients.

Journal of clinical immunology
2025

Effect of Tirzepatide in an Adolescent With Early-Onset Obesity, Hyperphagia, and Type 2 Diabetes.

Cureus
2025

Diabetes mellitus HNF4A-MODY in children from the Russian population: clinical and genetic features.

Frontiers in endocrinology
2025

Diabetes Insipidus as an Early Clinical Indicator of Wolfram Syndrome Type 1: Evidence From a Symptom-Based Screening Approach.

Pediatric diabetes
2025

Diabetic Ketoacidosis as the Presentation of Immune Dysregulation, Polyendocrinopathy, Enteropathy, and X-Linked Syndrome: A Case Report.

Case reports in pediatrics
2025

Population-scale gene-based analysis of whole-genome sequencing provides insights into metabolic health.

Nature genetics
2025

Genomic Sequencing in Oncocytic Adrenal Carcinoma May Provide Insights into Disease Progression and Treatment Options.

JCEM case reports
2025

Case Report: a family report of hereditary pancreatitis caused by SPINK1 and PRSS1 gene mutations.

Frontiers in genetics
2025

Cyclophosphamide post-haploidentical stem cell transplantation experience in an infant with IPEX syndrome.

Biomedica : revista del Instituto Nacional de Salud
2025

[194 + 2T>C;-215G>A] mutation of SPINK1 gene is associated with fibrocalculous pancreatic diabetes: A rare case report.

Medicine
2025

A Japanese infant with fulminant type 1 diabetes with disease-sensitive CSAD polymorphism and HLA haplotype.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
2025

Outcomes misaligned in mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS): implications for trial design.

Brain communications
2025

The Targets of Immune Adverse Events in Cancer Immunotherapy by Combined Check-point Inhibitors Resemble those Seen in IPEX Patients.

Journal of clinical immunology
2025

Complete loss of SLC30A8 in humans improves glucose metabolism and beta cell function.

Diabetologia
2025

A Case of Amyotrophic Lateral Sclerosis With Coexisting Maturity-onset Diabetes of the Young Type 5.

JCEM case reports
2025

Investigating the role of the ALPK1 signaling pathway in the pathogenesis of diabetic retinopathy.

Scientific reports
2025

Genotype-Phenotype Discrepancies in Family Members With a Novel Glucokinase Mutation: Insights Into GCK-MODY and Its Interplay With Insulin Resistance.

Diabetes
2025

Psychosis as a rare neuropsychiatric manifestation of Bardet-Biedl syndrome: A case report.

The Journal of international medical research
2025

Diabetes mellitus and pregnancy in Wolfram syndrome type 1: a case report with review of clinical and pathophysiological aspects.

Frontiers in medicine
2025

The miR-200 family in the context of obesity and type 2 diabetes.

Diabetes research and clinical practice
2025

Hereditary Hemochromatosis Type 2A Presenting With Hypogonadism, Diabetes, and Osteoporosis in a Young Woman.

JCEM case reports
2026

Association between SGLT2 inhibitors and genital cancer: a meta-analysis and mendelian randomization study.

Journal of endocrinological investigation
2025

Applying weighted Cox regression to genome-wide association studies of time-to-event phenotypes.

Nature computational science
2025

The X-Age Project to construct a Chinese aging clock.

Nature aging
2025

Neonatal Diabetes: 20-Year Experience from a Tertiary Care Pediatric Diabetes Clinic in North India.

Hormone research in paediatrics
2025

Long-term impact of growth hormone therapy on mortality and type 2 diabetes in Prader-Willi syndrome: a nationwide cohort study.

Frontiers in endocrinology
2026

Senescence-regulating agents remodel mesenchymal stem cell-schwann cell circuitry for diabetic bone regeneration.

Biomaterials
2025

Tailored Therapies for Hereditary Diabetes: Unraveling the Genetic Underpinnings of MODY and Neonatal Diabetes.

Current gene therapy
2025

Clinical characteristics and risk factors of metabolic dysfunction-associated steatotic liver disease in lean patients: results of the Polish Gallstone Surgery Registry.

Clinical and experimental hepatology
2025

Pediatric patient with maturity-onset diabetes of the young type 5 and 17q12 deletion syndrome: A case report.

Medicine international
2025

Neonatal diabetes mellitus is a significant feature of COXPD-24 caused by recessive NARS2 variants.

Diabetic medicine : a journal of the British Diabetic Association
2025

Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study.

Diabetes care
2025

De Novo KCNJ11 Mutation in an Infant With Neonatal Diabetes Mellitus Presenting as Diabetic Ketoacidosis: A Case Report and Literature Review.

Journal of investigative medicine high impact case reports
2025

Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES Trial.

Journal of the American Heart Association
2025

WFS1 gene mutation associated with pediatric diabetes mellitus and congenital deafness: A case report.

World journal of diabetes
2025

Subcutaneous phaeohyphomycosis due to a rare fungus Parathyridaria percutanea: First reported case from central India.

Indian journal of medical microbiology
2025

ABCC8 Mutation Causing Permanent Neonatal Diabetes Mellitus in Early Infancy: A Case Report.

AJP reports
2026

SLC30A8 Rare Variant Modify Contribution of Common Genetic and Lifestyle Factors toward Type 2 Diabetes Mellitus.

Diabetes &amp; metabolism journal
2025

[A rare case of autoimmune polyglandular syndrome type 2 in an elderly patient].

Medicina
2025

Inhibition of Ferroptosis by Adipose Stem Cell-Derived Apoptotic Vesicles Enhances Angiogenesis and Accelerates Diabetic Wound Healing.

International journal of nanomedicine
2025

Rare Variants in NEUROD1 and PDX1 Are Low-Penetrance Causes of MODY, Whereas Those in APPL1 and WFS1 Are Not Associated With MODY.

Diabetes
2025

Genotype-Phenotype Correlation in Lipoid Proteinosis: 15 Cases from Turkiye.

Molecular syndromology
2025

Mauriac syndrome: a rare complication in patients with type 1 diabetes mellitus.

Endocrinology, diabetes &amp; metabolism case reports
2025

Evaluating the Prophylactic and Nephroprotective Effects of Vitamin D and Metformin in Diabetic Nephropathy.

Oxidative medicine and cellular longevity
2025

Lipoprotein Lipase (LPL) Gene Mutation in a Girl With Diabetic Ketoacidosis, Acute Pancreatitis, and Hypertriglyceridemia.

Cureus
2025

Pheochromocytoma Associated With Neurofibromatosis Type 1: A Case Report.

Cureus
2025

First live birth after in vitro fertilization in a woman with Alström syndrome: a case report.

Frontiers in reproductive health
2025

Altered branched chain ketoacids underlie shared metabolic phenotypes in type 1 diabetes and maple syrup urine disease.

Communications medicine
2025

A rare likely pathogenic HLA-DRB1 variant with compromised immunity in severe COVID-19 patient and in-hospital mortality.

Personalized medicine
2025

Three Siblings With an Attenuated Presentation of Perlman Syndrome: A Case Report and Literature Review.

Molecular genetics &amp; genomic medicine
2025

Prenatal pembrolizumab exposure as the potential link among recurrent necrotizing enterocolitis, neonatal diabetes mellitus and exocrine pancreatic insufficiency: a case report.

Italian journal of pediatrics
2025

Gonadal Dysfunction in Wolfram Syndrome: A Prospective Study.

Diagnostics (Basel, Switzerland)
2025

A Case Report on Schistosoma and Gastric Cancer: Association or Causation?

Cureus
2025

A rare presentation of Wilson disease with normal levels of serum ceruloplasmin and copper and MODY: A case report.

Medicine
2025

Baseline 25-hydroxyvitamin D as a stronger protector against type 2 diabetes in the context of hyperuricemia and gout: a cohort study based on the UK biobank.

The Journal of nutritional biochemistry
2025

Liraglutide use in pediatric type 2 familial partial lipodystrophy caused by LMNA mutation: a case report.

BMC pediatrics
2025

Non-syndromic WFS1 mutations are not a rare cause of diabetes in Pakistan.

Diabetes research and clinical practice
2025

Epidemiology and clinical outcomes of clinically suspected multiple endocrine neoplasia type 1 in South Korea: a nationwide cohort study.

Frontiers in endocrinology
2025

The role of SLC19A2 variants in the wide spectrum of non-autoimmune abnormalities of glucose homeostasis.

Diabetologia
2025

Bi-allelic loss-of-function variants in POC5 cause a syndromic retinal, endocrine, and neuromuscular ciliopathy.

Genetics in medicine : official journal of the American College of Medical Genetics
2025

Management of pregnancy with metformin: Case reports for genetic insulin resistance syndrome and a literature review for gestational and type 2 diabetes.

Journal of diabetes investigation
2025

Regulation of Renal and Extrarenal Calcitriol Synthesis and Its Clinical Implications.

International journal of molecular sciences
2025

Pulmonary fungal infection caused by Rhizopus microsporus in type II diabetic patient:A case report.

Diagnostic microbiology and infectious disease
2025

A novel homozygous missense DNAJC3 variant in syndromic juvenile-onset diabetes.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2025

Exploring the causal association between pre-pregnancy obesity and pregnancy-related complications, and mediating pathways of obesity on adverse pregnancy outcomes: Insights from Mendelian randomization analysis.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
2025

Dual Diagnostic Dilemma: Gitelman Syndrome and Incidental Neuroendocrine Tumor in a Young Adult With Refractory Hypokalemia.

Cureus
2025

FURIN R81C variant: a link to type 2 diabetes via impaired enzymatic activity.

American journal of physiology. Endocrinology and metabolism
2025

Autosomal Dominant Calpainopathy in a Diabetic Patient Complicated by Functional Gitelman Syndrome.

Case reports in medicine
2025

Kearns-Sayre syndrome presenting with fanconi syndrome: a case report.

Translational pediatrics
2025

Genealogical Rabson-Mendenhall syndrome caused by INSR gene mutation.

American journal of physiology. Endocrinology and metabolism
2025

A case of a young patient with progressive vision loss: An atypical presentation of the rare Wolfram Syndrome in a Middle Eastern individual.

American journal of ophthalmology case reports
2025

Monogenic diabetes: An evidence-based clinical approach.

World journal of diabetes
2025

A Hidden Diagnosis: Neurogenic Bladder Leading to Acute Kidney Failure in Wolfram Syndrome.

Cureus
2025

Case Report: Beyond type 1 diabetes: a case of delayed MODY1 diagnosis and successful transition to sulfonylurea therapy.

Frontiers in medicine
2025

Neonatal diabetes-associated missense PDX1 variant disrupts chromatin association and protein-protein interaction.

JCI insight
2025

Mazdutide, a dual agonist targeting GLP-1R and GCGR, mitigates diabetes-associated cognitive dysfunction: mechanistic insights from multi-omics analysis.

EBioMedicine
2025

Safety and Effectiveness of Oral Glyburide Suspension in Neonatal Diabetes Mellitus: French Retrospective Cohort Study.

Journal of the Endocrine Society
2025

Association of cross-life-cycle body size and genetic risk with cardio-renal-metabolic conditions in adulthood: evidence from a prospective cohort study.

International journal of surgery (London, England)
2025

MDA5 variants trade antiviral activity for protection from autoimmune disease.

BMC medical genomics
2025

Brazilian expert consensus on the diagnosis, classification, screening for complications and treatment of familial partial lipodystrophy.

Diabetology &amp; metabolic syndrome
2026

An Invasive Macrolide/Lincosamide-Resistant Corynebacterium mucifaciens Isolate from a Patient with Diabetic Gangrene: Colonies with Mucoid Appearance Harboring a Fragment of erm(X).

Japanese journal of infectious diseases
2025

Phenome-wide association study and functional annotation of hemoglobin A1c-associated variants in African populations.

PloS one
2025

A Rare PTF1A Enhancer Mutation Causing Neonatal Diabetes Mellitus with Pancreatic Agenesis: Case Report and Considerations for Genetic Evaluation.

International journal of endocrinology and metabolism
2025

A rare combination of hypogonadotropic hypogonadism, GH deficiency and rectal atresia in a female with an FGFR1 variant: a case report and systematic review of the literature.

Endocrine
2025

Wolcott-Rallison syndrome: late-onset diabetes, multiple epiphyseal dysplasia, and acute liver failure - a case report.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2025

Pancreatic Comorbidities in Pediatric Celiac Disease: Exocrine Pancreatic Insufficiency, Pancreatitis, and Diabetes Mellitus.

Diagnostics (Basel, Switzerland)
2025

A case of SHORT syndrome with a novel genetic mutation diagnosed 19 years after the onset of diabetes.

Journal of diabetes investigation
2025

Unmasking the Rare but Lethal Cardiac Complications of Immune Checkpoint Inhibitor Therapy: A Review of Mechanisms, Risk Factors, and Management Strategies.

Current treatment options in oncology
2025

[Transition in cases of complex endocrine and diabetic diseases].

Innere Medizin (Heidelberg, Germany)
2025

Clonal hematopoiesis meets an autoinflammatory disease: the new paradigm of VEXAS syndrome.

Expert review of hematology
2025

Endocrine manifestations and long-term outcomes of patients with mitochondrial diseases.

Orphanet journal of rare diseases
2025

Accounting for the impact of rare variants on causal inference with RARE: a novel multivariable Mendelian randomization method.

Briefings in bioinformatics
2025

Novel and Ultrarare Heterozygous Missense LMNA Variants Causing Familial Partial Lipodystrophy.

The Journal of clinical endocrinology and metabolism
2025

sc-MULTI-omics approach in nano-rare diseases: understanding the pathophysiological mechanism of Mulvihill-Smith Syndrome.

Functional &amp; integrative genomics
2025

In Silico Analysis Identified Putative Pathogenic Missense Single Nucleotide Polymorphisms (SNPs) in the Human HNF1A Gene.

International journal of molecular sciences
2025

Diabetic Ketoacidosis With Schmidt Syndrome: An Autoimmune Polyendocrine Syndrome Type 2.

Cureus
2025

Case Report: Challenges of insulin and sulfonylurea dosing in an extremely premature infant for the management of KCNJ11-associated neonatal diabetes mellitus.

Frontiers in pediatrics
2025

A KDM6 A variant in a Chinese female patient with diabetes mellitus and oligomenorrhea: a case report.

Journal of medical case reports
2025

Focusing on Rare Variants Related to Maturity-Onset Diabetes of the Young in Children.

Pediatric diabetes
2024

Clinical Characteristics and Remission Monitoring of 6q24-Related Transient Neonatal Diabetes.

Pediatric diabetes
2025

Crossed Cerebellar Diaschisis in a Patient with MELAS Syndrome: A Case Report.

Cerebellum (London, England)
2026

Gonadal function in males with WFS1 spectrum disorder (Wolfram syndrome)-A European cohort perspective.

Andrology
2025

Neonatal hypoglycaemia in the offsprings of parents with maturity-onset diabetes of the young (MODY).

Journal of pediatric endocrinology &amp; metabolism : JPEM
2025

Autoimmune hyperglycemia: beyond type 1 diabetes.

Acta diabetologica
2025

Clinical settings in which human leukocyte antigen typing is still useful in the diagnosis of celiac disease.

World journal of gastroenterology
2025

Concomitant Pathologies and Their Impact on Parkinson Disease: A Narrative Overview of Current Evidence.

International journal of molecular sciences
2025

The Last Mile in Beta-Cell Replacement Therapy for Type 1 Diabetes: Time to Grow Up.

Transplant international : official journal of the European Society for Organ Transplantation
2025

Liraglutide Treatment Reverses Unconventional Cellular Defects in Induced Pluripotent Stem Cell-Derived β-Cells Harboring a Partially Functional WFS1 Variant.

Diabetes
2025

A Beacon of Hope: Confronting Bardet-Biedl Syndrome in Pakistan's Health Care Frontier.

AACE clinical case reports
2025

SGLT2 inhibition for patients with ADPKD - closing the evidence gap.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2025

Pathogenic variants prevalence patients with diabetic kidney disease in Japan: A descriptive study.

Journal of diabetes investigation

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Diabetes mellitus genéticos raros.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Diabetes mellitus genéticos raros

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Clinical Characterization of Atypical Diabetes: Insights from the GENEPEDIAB Study into the Spectrum Between Type 1 and Monogenic Diabetes.
    Cells· 2026· PMID 41827917mais citado
  2. Original research: Amplification of genetic and metabolic factors in alpha-1 antitrypsin deficiency.
    Hepatology (Baltimore, Md.)· 2026· PMID 41812027mais citado
  3. Novel Homozygous Variants in CIDEC and WRN in a Young Female with Lipodystrophy and Thyroid Cancer.
    International journal of molecular sciences· 2026· PMID 41596298mais citado
  4. Skeletal Muscle HSF1 Alleviates Age-Associated Sarcopenia and Mitochondrial Function Decline via SIRT3-PGC1&#x3b1; Axis.
    Advanced science (Weinheim, Baden-Wurttemberg, Germany)· 2026· PMID 41400028mais citado
  5. Transgenic overexpression of miR-486 and sAnk1.5 does not alter glucose handling in mice.
    Biochimica et biophysica acta. Molecular cell research· 2026· PMID 41260536mais citado
  6. Age- and diet-dependent progression of retinal microvascular injury in GCK-MODY under metabolic stress.
    Front Endocrinol (Lausanne)· 2026· PMID 41869024recente
  7. A type 2 diabetes patient with three years of persistent abdominal pain: the culprit was variegate porphyria-a case report.
    Front Endocrinol (Lausanne)· 2026· PMID 41837145recente
  8. Pediatric Hepatocyte Nuclear Factor 1B (HNF1B) Disease: Diabetes and Endocrine Manifestations.
    Pediatr Diabetes· 2025· PMID 41809577recente
  9. A Novel Autoimmune Presentation of Wiskott-Aldrich Syndrome: Type 1 Diabetes.
    Immun Inflamm Dis· 2026· PMID 41757399recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:183625(Orphanet)
  2. MONDO:0015967(MONDO)
  3. Variantes catalogadas(ClinVar)
  4. Busca completa no PubMed(PubMed)
  5. Q55785854(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Diabetes mellitus genéticos raros
Compêndio · Raras BR

Diabetes mellitus genéticos raros

ORPHA:183625 · MONDO:0015967
MedGen
UMLS
C5680537
Repurposing
40 candidatos
acarboseglucosidase inhibitor
acetohexamideATP channel blocker
alogliptindipeptidyl peptidase inhibitor
+17 outros
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades